<DOC>
	<DOC>NCT02382367</DOC>
	<brief_summary>The main objective of this trial is to evaluate the prevalence of alpha-1 antitrypsin quantitative and functional deficiency in an adult French population presenting with pulmonary emphysema. Phenotypic and genotypic studies will be carried whenever quantitative and/or functional deficiency will be displayed.</brief_summary>
	<brief_title>Prevalence of Alpha-1 Antitrypsin Dysfunction in Pulmonary Emphysema</brief_title>
	<detailed_description />
	<mesh_term>Emphysema</mesh_term>
	<mesh_term>Pulmonary Emphysema</mesh_term>
	<mesh_term>Alpha 1-Antitrypsin</mesh_term>
	<mesh_term>Protein C Inhibitor</mesh_term>
	<criteria>Pulmonary emphysema highlighted by computed tomography Ratio Forced Expiratory Volume in 1 second (FEV1) / Vital Capacity (VC) &lt; 70% measured by lung function test Hepatic transplant Patient under legal protection Patient not benefiting from the French Health Insurance</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>December 2015</verification_date>
</DOC>